World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
47111
World Ranking
12909
National Ranking
6598

Overview

Daniel G. Haller is affiliated with the University of Pennsylvania in the United States and has contributed substantially to the field of medicine, with a particular focus on oncology.

Their research prominently addresses colorectal cancer treatments and studies, with notable attention to surgical treatments and genetic factors related to colorectal cancer. Other main topics in their work include gastric cancer management and outcomes, colorectal cancer screening and detection, colorectal and anal carcinomas, as well as pancreatic and hepatic oncology research.

Haller has published extensively in the discipline of oncology, with specific subfields including pulmonary and respiratory medicine, pathology and forensic medicine, surgery, and cancer research.

Frequent publication venues for their research include:

  • Journal of Clinical Oncology
  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Clinical Colorectal Cancer
  • JAMA Oncology

Frequent co-authors collaborating with Haller are:

  • Aimery de Gramont (13 publications)
  • Thierry André (12 publications)
  • Qian Shi (12 publications)
  • Richard M. Goldberg (11 publications)
  • Greg Yothers (10 publications)

Significant recent publications by Daniel G. Haller include:

  • "Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials", 2020, Journal of Clinical Oncology
  • "Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34,640 Patients in the ACCENT Database", 2020, JNCI Journal of the National Cancer Institute
  • "Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials", 2022, Journal of Clinical Oncology
  • "Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database", 2021, JNCI Journal of the National Cancer Institute
  • "Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients", 2021, Clinical Colorectal Cancer

Best Publications

  • Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

    John S. Macdonald;Stephen R. Smalley;Jacqueline Benedetti;Scott A. Hundahl

  • Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    Moertel Cg;Fleming Tr;Macdonald Js;Haller Dg

  • American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

    Al B. Benson;Deborah Schrag;Mark R. Somerfield;Alfred M. Cohen

  • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

    David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan

  • Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

    Michael J. O'Connell;James A. Martenson;Harry S. Wieand;James E. Krook

  • Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

    T.E. Le Voyer;E.R. Sigurdson;A.L. Hanlon;R.J. Mayer

  • Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Sharlene Gill;Charles L. Loprinzi;Daniel J. Sargent;Stephan D. Thomé

  • Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

    Daniel J. Sargent;Richard M. Goldberg;Stacy D. Jacobson;John S. Macdonald

  • Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

    Toshiaki Watanabe;Tsung Teh Wu;Paul J. Catalano;Paul J. Catalano;Takashi Ueki

  • Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

    Jordan D. Berlin;Paul Catalano;James P. Thomas;John W. Kugler

  • Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

    Stephen R. Smalley;Jacqueline K. Benedetti;Daniel G. Haller;Scott A. Hundahl

  • Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

    Mace L. Rothenberg;Amit M. Oza;Robert H. Bigelow;Jordan D. Berlin

  • Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

    Daniel G. Haller;Josep Tabernero;Jean Maroun;Filippo De Braud

  • Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel J. Sargent;Harry S. Wieand;Daniel G. Haller;Richard Gray

  • Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

    M J O'Connell;J A Mailliard;M J Kahn;J S Macdonald

  • Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel Sargent;Alberto Sobrero;Axel Grothey;Michael J. O'Connell

  • Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

    David P. Kelsen;Katryn A. Winter;Leonard L. Gunderson;Joanne Mortimer

  • Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

    Adam C. Berger;Elin R. Sigurdson;Thomas LeVoyer;Alexandra Hanlon

  • An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

Frequent Co-Authors

Al B. Benson
Al B. Benson Northwestern University
Paul J. Catalano
Paul J. Catalano Harvard University
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Peter J. O'Dwyer
Peter J. O'Dwyer University of Pennsylvania
Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
Hans-Joachim Schmoll
Hans-Joachim Schmoll Martin Luther University Halle-Wittenberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can help you diversify your skill set and career opportunities in the healthcare field. If you’re interested in preventative medicine and nutrition, an online bs in nutrition can provide a strong foundation in dietary science and health promotion for a variety of roles.

For those pursuing healthcare leadership or administration, there are accredited mha programs that prepare graduates for management jobs in hospitals and clinics. These programs offer flexibility for working professionals, while ensuring that studies meet high accreditation standards.

Registered nurses looking for advancement may benefit from rn to bsn online no clinicals accredited options. These accredited programs are tailored for RNs who need a flexible, clinical-free pathway to earn their BSN.

If you’re aiming for the peak of nursing practice, accelerated dnp programs provide an efficient route to a Doctor of Nursing Practice. These online pathways help experienced nurses move quickly into advanced leadership, education, or clinical roles.

Best Scientists Citing Daniel G. Haller

Trending Scientists

Recently Published Articles